Utilizing a reductionist model to study host-microbe interactions in intestinal inflammation.

Defined consortium Gut microbiota Immune dysregulation Intestinal inflammation Pathobiont Wiskott-Aldrich syndrome

Journal

Microbiome
ISSN: 2049-2618
Titre abrégé: Microbiome
Pays: England
ID NLM: 101615147

Informations de publication

Date de publication:
03 11 2021
Historique:
received: 18 05 2021
accepted: 10 09 2021
entrez: 4 11 2021
pubmed: 5 11 2021
medline: 22 3 2022
Statut: epublish

Résumé

The gut microbiome is altered in patients with inflammatory bowel disease, yet how these alterations contribute to intestinal inflammation is poorly understood. Murine models have demonstrated the importance of the microbiome in colitis since colitis fails to develop in many genetically susceptible animal models when re-derived into germ-free environments. We have previously shown that Wiskott-Aldrich syndrome protein (WASP)-deficient mice (Was Was These studies indicate that the effect of a microbe on the immune system can be context dependent, with the same bacteria eliciting a tolerogenic response under homeostatic conditions but promoting inflammation in immune-dysregulated hosts. Furthermore, in inflamed environments, some bacteria up-regulate genes that enhance their fitness and immunogenicity, while other bacteria are less able to adapt and decrease in abundance. These findings highlight the importance of studying host-microbe interactions in different contexts and considering how the transcriptional profile and fitness of bacteria may change in different hosts when developing microbiota-based therapeutics. Video abstract.

Sections du résumé

BACKGROUND
The gut microbiome is altered in patients with inflammatory bowel disease, yet how these alterations contribute to intestinal inflammation is poorly understood. Murine models have demonstrated the importance of the microbiome in colitis since colitis fails to develop in many genetically susceptible animal models when re-derived into germ-free environments. We have previously shown that Wiskott-Aldrich syndrome protein (WASP)-deficient mice (Was
RESULTS
Was
CONCLUSIONS
These studies indicate that the effect of a microbe on the immune system can be context dependent, with the same bacteria eliciting a tolerogenic response under homeostatic conditions but promoting inflammation in immune-dysregulated hosts. Furthermore, in inflamed environments, some bacteria up-regulate genes that enhance their fitness and immunogenicity, while other bacteria are less able to adapt and decrease in abundance. These findings highlight the importance of studying host-microbe interactions in different contexts and considering how the transcriptional profile and fitness of bacteria may change in different hosts when developing microbiota-based therapeutics. Video abstract.

Identifiants

pubmed: 34732258
doi: 10.1186/s40168-021-01161-3
pii: 10.1186/s40168-021-01161-3
pmc: PMC8565002
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Video-Audio Media

Langues

eng

Sous-ensembles de citation

IM

Pagination

215

Subventions

Organisme : NIDDK NIH HHS
ID : P30 DK034854
Pays : United States

Informations de copyright

© 2021. The Author(s).

Références

Nature. 2012 Nov 1;491(7422):119-24
pubmed: 23128233
Sci Immunol. 2019 Apr 19;4(34):
pubmed: 31004013
Sci Immunol. 2017 Jul 21;2(13):
pubmed: 28733471
Cochrane Database Syst Rev. 2018 Nov 13;11:CD012774
pubmed: 30480772
Nature. 2015 Mar 5;519(7541):92-6
pubmed: 25731162
Nat Immunol. 2011 Apr;12(4):320-6
pubmed: 21336274
Proc Natl Acad Sci U S A. 2019 Dec 3;116(49):24760-24769
pubmed: 31740609
Gut. 2016 Feb;65(2):225-37
pubmed: 25887379
Nature. 2011 Sep 14;477(7366):596-600
pubmed: 21918512
J Biol Chem. 1999 Oct 1;274(40):28083-6
pubmed: 10497158
PLoS Pathog. 2020 Apr 10;16(4):e1008466
pubmed: 32275693
Gut. 2014 Feb;63(2):281-91
pubmed: 23426893
Cell. 2007 Oct 5;131(1):33-45
pubmed: 17923086
Nat Genet. 2015 Sep;47(9):979-986
pubmed: 26192919
Pediatrics. 2003 May;111(5 Pt 1):e622-7
pubmed: 12728121
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
PLoS One. 2013 Apr 22;8(4):e61217
pubmed: 23630581
J Clin Invest. 2008 Feb;118(2):534-44
pubmed: 18172556
Infect Immun. 2011 Sep;79(9):3711-7
pubmed: 21730091
Gut. 2014 Oct;63(10):1566-77
pubmed: 24436141
Inflamm Bowel Dis. 2013 Sep;19(10):2041-50
pubmed: 23820270
Am J Gastroenterol. 2011 Apr;106(4):661-73
pubmed: 21407187
Genome Biol. 2014;15(12):550
pubmed: 25516281
Science. 2013 Aug 2;341(6145):569-73
pubmed: 23828891
Nature. 2013 Dec 19;504(7480):451-5
pubmed: 24226773
Cell Host Microbe. 2017 Feb 8;21(2):208-219
pubmed: 28182951
Gastroenterology. 2007 Oct;133(4):1188-97
pubmed: 17764675
ISME J. 2012 Nov;6(11):2091-106
pubmed: 22572638
Bioinformatics. 2010 Oct 1;26(19):2460-1
pubmed: 20709691
Vaccines (Basel). 2020 Dec 17;8(4):
pubmed: 33348708
Front Immunol. 2020 Feb 18;11:214
pubmed: 32133003
Int J Syst Evol Microbiol. 2005 May;55(Pt 3):1199-1204
pubmed: 15879255
Gut. 2019 Feb;68(2):248-262
pubmed: 30007918
Nat Commun. 2015 Sep 22;6:8292
pubmed: 26392213
Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6
pubmed: 23193283
Gut. 2014 Jul;63(7):1069-80
pubmed: 23896971
Immunity. 1998 Jul;9(1):81-91
pubmed: 9697838
J Clin Invest. 2004 May;113(9):1296-306
pubmed: 15124021
ISME J. 2017 Feb;11(2):426-438
pubmed: 27824342
Nucleic Acids Res. 2019 May 7;47(8):e47
pubmed: 30783653
ILAR J. 2015;56(2):169-78
pubmed: 26323627
Genes Dev. 1992 Dec;6(12B):2646-54
pubmed: 1340475
PLoS Pathog. 2016 Jan 07;12(1):e1005295
pubmed: 26742105
Nature. 2008 May 29;453(7195):620-5
pubmed: 18509436
Lancet. 1991 Sep 28;338(8770):771-4
pubmed: 1681159
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
J Crohns Colitis. 2017 Oct 1;11(10):1180-1199
pubmed: 28486648
J Bacteriol. 2015 Oct;197(19):3206-15
pubmed: 26216848
Nature. 2018 Feb 15;554(7692):373-377
pubmed: 29414937
Appl Environ Microbiol. 2002 Jul;68(7):3401-7
pubmed: 12089021
Cell. 1994 Aug 26;78(4):635-44
pubmed: 8069912
Nucleic Acids Res. 2014 Jan;42(Database issue):D633-42
pubmed: 24288368
Sci Rep. 2017 Dec 13;7(1):17522
pubmed: 29235503
J Bacteriol. 1992 Oct;174(19):6256-63
pubmed: 1400176
J Exp Med. 2013 Jun 3;210(6):1117-24
pubmed: 23690441
Nat Med. 2019 Jul;25(7):1104-1109
pubmed: 31235964
Nature. 2018 Jan 11;553(7687):208-211
pubmed: 29323293
Gastroenterology. 1998 Feb;114(2):262-7
pubmed: 9453485
Proc Natl Acad Sci U S A. 1999 Nov 23;96(24):13732-7
pubmed: 10570141
Appl Environ Microbiol. 1999 Aug;65(8):3287-92
pubmed: 10427008
Nat Methods. 2018 Nov;15(11):962-968
pubmed: 30377376
Infect Immun. 2004 Mar;72(3):1364-73
pubmed: 14977940
Annu Rev Immunol. 2002;20:495-549
pubmed: 11861611
Nat Rev Gastroenterol Hepatol. 2021 Jul;18(7):503-513
pubmed: 33907321
Cell Host Microbe. 2013 Nov 13;14(5):571-81
pubmed: 24237702
J Exp Med. 1965 Jul 1;122:77-82
pubmed: 14325475
Nat Genet. 2017 Feb;49(2):256-261
pubmed: 28067908
Gut. 2002 Feb;50(2):273-83
pubmed: 11788573
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
Nat Rev Immunol. 2010 Mar;10(3):182-92
pubmed: 20182458
Gastroenterology. 2020 Mar;158(4):930-946.e1
pubmed: 31812509
Genome Announc. 2014 Apr 10;2(2):
pubmed: 24723722
Nature. 2013 Dec 19;504(7480):446-50
pubmed: 24226770
Cell Host Microbe. 2017 Dec 13;22(6):733-745.e5
pubmed: 29241040
Cell Host Microbe. 2014 Mar 12;15(3):382-392
pubmed: 24629344

Auteurs

Amy M Tsou (AM)

Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, MA, USA. amt9052@med.cornell.edu.
Harvard Medical School, Boston, MA, USA. amt9052@med.cornell.edu.
Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medical College, New York, NY, USA. amt9052@med.cornell.edu.
Division of Pediatric Gastroenterology and Nutrition, Weill Cornell Medical College, New York, NY, USA. amt9052@med.cornell.edu.

Jeremy A Goettel (JA)

Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
Division of Gastroenterology, Hepatology, and Nutrition, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.

Bin Bao (B)

Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Amlan Biswas (A)

Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Yu Hui Kang (YH)

Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Naresh S Redhu (NS)

Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Kaiyue Peng (K)

Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, MA, USA.
Department of Gastroenterology, Children's Hospital of Fudan University, Shanghai, China.

Gregory G Putzel (GG)

Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medical College, New York, NY, USA.

Jeffrey Saltzman (J)

Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, MA, USA.

Ryan Kelly (R)

Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, MA, USA.

Jordan Gringauz (J)

Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, MA, USA.

Jared Barends (J)

Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, MA, USA.

Mai Hatazaki (M)

Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medical College, New York, NY, USA.

Sandra M Frei (SM)

Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Rohini Emani (R)

Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Ying Huang (Y)

Department of Gastroenterology, Children's Hospital of Fudan University, Shanghai, China.

Zeli Shen (Z)

Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA, USA.

James G Fox (JG)

Division of Comparative Medicine, Massachusetts Institute of Technology, Cambridge, MA, USA.

Jonathan N Glickman (JN)

Harvard Medical School, Boston, MA, USA.
Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA, USA.

Bruce H Horwitz (BH)

Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.
Division of Emergency Medicine, Boston Children's Hospital, Boston, MA, USA.

Scott B Snapper (SB)

Division of Gastroenterology, Hepatology and Nutrition, Boston Children's Hospital, Boston, MA, USA. scott.snapper@childrens.harvard.edu.
Harvard Medical School, Boston, MA, USA. scott.snapper@childrens.harvard.edu.
Division of Gastroenterology, Brigham and Women's Hospital, Boston, MA, USA. scott.snapper@childrens.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH